This systematic review provides a summary of the blood protein biomarkers that have been studied for the diagnosis of acute ischemic stroke.
Browsing: Cerebrovascular disease
A biomarker to aid in the diagnosis of ischemic stroke and its causes would be of value in acute clinical practice. It could have applications to aid in acute stroke treatment decisions for tissue plasminogen activator and/or the triage to endovascular therapy. This review provides an overview of RNA as a novel biomarker for the diagnosis and assessment of ischemic stroke.
This year’s WBD theme is ‘Stroke is a brain attack – prevent it and treat it’ – in this interview, we learn more about WBD and what will the WFN be doing to mark this.
A project aimed at helping people who have had a stroke, is among the programs approved today by the governing Board of CIRM.
Researchers have provided evidence indicating that patients with hypertension suffer from more severe Parkinson’s disease than those with normal blood pressure.
New research indicates that drops in blood pressure when standing up could increase the likelihood of developing cognitive decline and dementia in later years.
Researcher have developed a compound, P7C3-A20, which not only prevents mature neurons dying during stroke, but also encourages neurogenesis after a stroke to protect cognitive function.
Diagnosis of cSAH is challenging given its subtle findings, and management is empiric as there are only a few case series in literature – in this case report, Mao, Addess and Valsamis report a case of cortical subarachnoid hemorrhage (cSAH) and discuss its management
Research demonstrates that the onset of hypertension in later life is associated with a reduced risk of dementia after 90 years of age.